Wentao Fang
Papers
6
Total Citations
63
H-Index
5
About
Dr. Wentao Fang is a leading thoracic surgeon whose research focuses on optimizing surgical management for thymic malignancies and lung cancer, with a strong emphasis on international collaboration and surgical education. His most impactful work includes a landmark 2017 study analyzing over 1,400 patients across Europe, North America, and Asia, which compared surgical approaches and resection extents for early-stage thymic tumors, providing critical evidence for global standardization of care. Dr. Fang also spearheaded an international Delphi consensus study to identify priority technical procedures for simulation-based training in thoracic surgery, directly shaping future curricula. Notably, he leads the NEOS trial investigating osimertinib as neoadjuvant therapy for EGFR-mutated resectable lung adenocarcinoma, with updated results showing promising outcomes. Beyond these contributions, Dr. Fang has authored multiple annual reports from Shanghai Chest Hospital, documenting the service’s high-volume surgical outcomes and continuous quality improvement. His work has garnered significant citations, with his thymic tumor study alone cited 27 times, reflecting its influence on clinical practice. Dr. Fang’s dedication to evidence-based surgery, global consensus-building, and training innovation marks him as a pivotal figure in advancing thoracic surgical care worldwide.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3
- 4
- 5
- 6